文献速递心脏核医学

银屑病患者的冠状动脉微血管功能障碍

Coronary microvascular dysfunction in patients with psoriasis.
PubMed 文献 · J Nucl Cardiol · 2020-05-17

本研究为连续回顾性队列研究,纳入心肌灌注正常且左心室射血分数>50%的银屑病患者62例及无银屑病的匹配对照112例,用PET定量心肌灌注与心肌血流储备(MFR),并以半定量CT冠状动脉钙化评估动脉粥样硬化负荷。银屑病患者冠状动脉微血管功能障碍(CMD,定义为MFR<2)患病率为61.3%,对照为38.4%(P=.004);校正后MFR在银屑病患者中降低更明显(2.3±.81 vs 1.92±.65,P=.001),而两组钙化评分所反映的粥样硬化负荷相似。

要点

  • 银屑病患者CMD(MFR<2)患病率为61.3%,匹配对照为38.4%(P=.004)。
  • 校正后MFR在银屑病患者为2.3±.81,对照为1.92±.65(P=.001)。
  • 两组定性钙化评分所反映的动脉粥样硬化负荷相似。

核心结论

  • 银屑病无明显冠状动脉疾病患者中冠状动脉血管舒缩异常患病率高,且不能完全由常见冠状动脉危险因素或动脉粥样硬化负荷解释。

研究设计与样本

  • 连续回顾性队列研究,纳入心肌灌注正常且左心室射血分数>50%的银屑病患者62例及无银屑病的匹配对照112例。
  • 采用PET成像定量心肌灌注与心肌血流储备(MFR),并以半定量CT冠状动脉钙化评估动脉粥样硬化负荷。

主要发现

  • CMD(定义为MFR<2)患病率在银屑病患者为61.3%,匹配对照为38.4%(P=.004)。
  • 校正后MFR在银屑病患者为2.3±.81,对照为1.92±.65(P=.001),银屑病患者降低更明显。
  • 定性钙化评分所评估的动脉粥样硬化负荷在银屑病与对照之间相似。

关键数值与推荐

  • CMD定义为MFR<2。
  • 银屑病患者CMD患病率61.3%,匹配对照38.4%(P=.004)。
  • 校正后MFR银屑病患者2.3±.81 vs 对照1.92±.65(P=.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is a common chronic inflammatory skin disorder that is associated with excess cardiovascular risk. Inflammation is a key mediator in the onset and progression of these cardiometabolic abnormalities; however, the excess cardiovascular risk conferred by psoriatic disease remains understudied. We investigated the prevalence and severity of CMD in patients with psoriasis and determined whether CMD is a result of CV risk factors and atherosclerotic burden. METHODS: This was a consecutive retrospective cohort study of patients with psoriasis, normal myocardial perfusion, and LV ejection fraction (EF) > 50% (N = 62) and matched controls without psoriasis (N = 112). Myocardial perfusion and myocardial flow reserve (MFR) were quantified using PET imaging. Atherosclerotic burden was determined by semi-quantitative computed tomography (CT) coronary calcium assessment. RESULTS: The prevalence of CMD (defined as MFR < 2) was 61.3% in patients with psoriatic disease, compared to 38.4% in a matched control population (P = .004). Furthermore, patients with psoriasis had a more severe reduction in adjusted MFR (2.3 ± .81 vs 1.92 ± .65, respectively, P = .001). The degree of atherosclerotic burden, as assessed by qualitative calcium score, was similar between psoriasis and controls. CONCLUSIONS: Patients with psoriasis without overt CAD demonstrated a high prevalence of coronary vasomotor abnormalities that are not entirely accounted for by the commonly associated coronary risk factors or the burden of atherosclerosis.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Weber B, Perez-Chada LM, Divakaran S, et al. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2020. PMID: 32419071. doi:10.1007/s12350-020-02166-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。